Neurocrine Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
127.79
|
|
Average Rating
|
3.96
|
|
# Strong Buys
|
11
|
|
# Buys
|
5
|
|
# Holds
|
10
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.80
|
0.69
|
-0.11
|
-13.75%
|
|
2022-06-30
|
0.60
|
-0.18
|
-0.78
|
-130.00%
|
|
2022-03-31
|
0.35
|
0.14
|
-0.21
|
-60.00%
|
|
2021-12-31
|
0.52
|
-0.08
|
-0.60
|
-115.38%
|
|
2021-09-30
|
0.60
|
0.23
|
-0.37
|
-61.67%
|
|
2021-06-30
|
0.48
|
0.43
|
-0.05
|
-10.42%
|
|
2021-03-31
|
0.51
|
0.33
|
-0.18
|
-35.29%
|
|
2020-12-31
|
0.54
|
3.58
|
3.04
|
562.96%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.65
|
|
2021-12-31
|
0.91
|
|
2020-12-31
|
4.16
|
|
2019-12-31
|
0.33
|
|
2018-12-31
|
0.17
|
|
2017-12-31
|
-1.64
|
|
2016-12-31
|
-1.62
|
|
2015-12-31
|
-1.03
|
|
2014-12-31
|
-0.82
|
|
2013-12-31
|
-0.69
|
|
2012-12-31
|
0.07
|
|
2011-12-31
|
0.67
|
|
2010-12-31
|
-0.18
|
|
2009-12-31
|
-1.31
|
|
2008-12-31
|
-2.31
|
|
2007-12-31
|
-2.98
|
|
2006-12-31
|
-2.84
|
|
2005-12-31
|
-0.63
|
|
2004-12-31
|
-1.28
|
|
2003-12-31
|
-0.98
|
|
2002-12-31
|
-3.10
|
|
2001-12-31
|
-1.41
|
|
2000-12-31
|
-1.18
|
|
1999-12-31
|
-0.88
|
|
1998-12-31
|
-0.61
|
|
1997-12-31
|
0.30
|
|
1996-12-31
|
0.33
|